Jan 21, 2021By DDNews StaffBreathing easier with statins?InVixa, UC Davis team up to develop inhaled statins for the treatment of COVID-19
Jan 04, 2021By Mel J. YeatesAgreeing on antibioticsHoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
Dec 22, 2020By Mel J. YeatesAmgen licenses AMG 634 to MDGHAMG 634, an investigational treatment for tuberculosis and leprosy, has been licensed to Medicines Development for Global Health
Infectious Disease & VaccinesDec 15, 2020By DDNews StaffCOVID-19 vaccine candidate COVI-VAC heads to Phase 1COVI-VAC is a single dose, intranasal live attenuated vaccine for COVID-19
Nov 16, 2020By Mel J. YeatesOX40L and CD30L blockade could improve asthmaStudy suggests that future asthma therapies should target OX40L and CD30L
Jul 07, 2020By DDNews StaffAn oral option for gastrointestinal problemsZeposia could help solve the unmet need of more oral drugs for moderate to severe CD and UC patients
Jul 07, 2020By DDNews StaffTrying to take pediatric brain tumors down a pegZiopharm Oncology doses first DIPG patient in Phase 1/2 trial of Controlled IL-12
Jul 06, 2020By DDNews StaffLooking at the frontrunnersThree compounds are in the spotlight now as new and repurposed drug options are examined for COVID-19
Jul 01, 2020By DDNews StaffAnti-inflammatory TAT CARMIL1 discovery offers hope for COVID-19Peptide combination could be effective in reducing damage caused by COVID-19 infections